Concentra Group Holdings Parent, Inc. (CON)
Data as of , from SEC Form 4 filings.
See up to 3 months of CON. The 7-day demo opens the 1M and 3M ranges and puts CON on your watchlist.
Start 7-day demoLatest CON insider trades
About Concentra Group Holdings Parent, Inc. (CON)
Concentra Group Holdings Parent, Inc. files with the SEC under CIK 0002014596 and is classified as specialty outpatient facilities, nec. We track it alongside the rest of the Health Care sector.
CON Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 130,000 | $4.14M |
| Derivative transaction | 10 | 2,000,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CON insider transactions (Form 4)
3963 Form 4 filings on record, the earliest from Nov 25, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert A. Ortenzio - Director | Derivative | Common Stock | 770,000 | $34.65 | $26.68M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 150,000 | $34.65 | $5.20M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 30,000 | $34.65 | $1.04M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 30,000 | $34.65 | $1.04M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 20,000 | $34.65 | $693K | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 770,000 | $34.65 | $26.68M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 150,000 | $34.65 | $5.20M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 30,000 | $34.65 | $1.04M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 30,000 | $35.65 | $1.07M | |
| Robert A. Ortenzio - Director | Derivative | Common Stock | 20,000 | $34.65 | $693K | |
| Robert A. Ortenzio - Director | Open-market sale | Common Stock | 130,000 | $31.84 footnote F1 | $4.14M | |
| ||||||
| Robert A. Ortenzio - Director | Open-market sale | Common Stock | 130,000 | $30.50 footnote F1 | $3.96M | |
| ||||||
| Robert A. Ortenzio - Director | Open-market sale | Common Stock | 130,000 | $25.00 footnote F1 | $3.25M | |
| ||||||
| Robert A. Ortenzio - Director | Open-market sale | Common Stock | 130,000 | $25.00 | $3.25M | |
| Timothy F. Ryan - Officer | Tax withholding / forfeiture | Common Stock | 5,903 | $21.04 | $124K | |
| John Robert Anderson Jr. - Officer | Tax withholding / forfeiture | Common Stock | 6,540 | $21.04 | $138K | |
| John A. Delorimier - Officer | Tax withholding / forfeiture | Common Stock | 6,428 | $21.04 | $135K | |
| Douglas R. McAndrew - Officer | Tax withholding / forfeiture | Common Stock | 5,903 | $21.04 | $124K | |
| Su Zan Nelson - Officer | Tax withholding / forfeiture | Common Stock | 5,903 | $21.04 | $124K | |
| Thomas A. Devasia - Officer | Tax withholding / forfeiture | Common Stock | 5,903 | $21.04 | $124K | |
| Greg M. Gilbert - Officer | Tax withholding / forfeiture | Common Stock | 5,903 | $21.04 | $124K | |
| Michael D. Rhine - Officer | Tax withholding / forfeiture | Common Stock | 3,935 | $21.04 | $83K | |
| Danielle Kendall - Officer | Tax withholding / forfeiture | Common Stock | 3,935 | $21.04 | $83K | |
| Matthew T. Dicanio - Officer | Tax withholding / forfeiture | Common Stock | 17,708 | $21.04 | $373K | |
| Jonathan P. Conser - Officer | Tax withholding / forfeiture | Common Stock | 5,903 | $21.04 | $124K | |
| Giovanni Gallara - Officer | Tax withholding / forfeiture | Common Stock | 6,563 | $21.04 | $138K | |
| Michael A. Kosuth - Officer | Tax withholding / forfeiture | Common Stock | 6,449 | $21.04 | $136K | |
| Robert A. Ortenzio - Director | Gift | Common Stock | 100,000 | $0.00 | - | |
| Michael D. Rhine - Officer | Grant or award | Common Stock | 40,000 | $0.00 | - | |
| Michael A. Kosuth - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| Matthew T. Dicanio - Officer | Grant or award | Common Stock | 180,000 | $0.00 | - | |
| Giovanni Gallara - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| William Keith Newton - Officer | Grant or award | Common Stock | 225,000 | $0.00 | - | |
| Timothy F. Ryan - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| Vipin Gopal - Director | Grant or award | Common Stock | 7,748 | $0.00 | - | |
| Vipin Gopal - Director | Grant or award | Common Stock | 7,748 | $0.00 | - | |
| Douglas R. McAndrew - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| Thomas A. Devasia - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| Danielle Kendall - Officer | Grant or award | Common Stock | 40,000 | $0.00 | - | |
Recent CON Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ORTENZIO ROBERT A | Director | 130,000 | $4.11M | View on EDGAR | |
| - | - | - | - |
Stock trades in CON disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Lisa C. McClainRepublican, MI-09 | Sale |
CON insider trading FAQ
What is the latest insider trade for CON?
Concentra Group Holdings Parent, Inc. (CON) had 3 insider filings in the last 90 days, with the most recent on 2026-09-01. The full record for CON runs to 63 Form 4 filings, the earliest from 2024-11-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CON stock?
No insider purchases of CON were filed in the last 90 days.
How many insiders are selling CON stock?
1 insider sale of CON was filed in the last 90 days, totaling $4.14M.
Where can I see CON SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CON Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert A. Ortenzio view on EDGAR
- - Robert A. Ortenzio view on EDGAR
- - Robert A. Ortenzio view on EDGAR
- - Robert A. Ortenzio view on EDGAR
- - Robert A. Ortenzio view on EDGAR
- - Robert A. Ortenzio view on EDGAR
- - Timothy F. Ryan view on EDGAR
- - John Robert Anderson Jr. view on EDGAR
- - John A. Delorimier view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CON's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CON with a 7-day demo
- CON on your watchlist
- Every CON Form 4 filing on record
- Up to 3 months of CON price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
